← Leaderboards
Tilahun D Yilma
University Of California Davis
$5,862,063
Attributed
$6,308,188
Total exposure
12
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $892.3K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$6,308,188 · 12
By mechanism
R01$2,745,044 · 2
U01$1,690,685 · 1
R56$892,251 · 1
P51$534,708 · 7
R21$445,500 · 1
Top collaborators
- Ian Manning Kennedy1 shared
Most similar at University Of California Davis
Same institution · by research overlap
- Paulo H. Verardi$3,754,968
Others in their field
Top investigators on “Vaccinia Virus”
- George R Painter · Chimerix, Inc.$36,309,505
- Daniel F. Hoft · Saint Louis University$26,271,892
- Rama Rao Amara · Emory University$21,210,426
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$18,568,832
- Bertram L. Jacobs · Arizona State University-Tempe Campus$16,467,268
- Stewart H Shuman · Sloan-Kettering Institute For Cancer Res$15,348,129
Research focus
Vaccinia VirusVaccine DevelopmentSmallpox VaccineSimian Immunodeficiency VirusInterferon GammaMacaca MulattaCellular ImmunityAids VaccinesEnzyme Linked Immunosorbent AssayVirus DiseasesGag ProteinVector VaccineCommunicable DiseasesBaseVaccinesCytotoxic T LymphocyteRecombinant VirusFundingActive ImmunizationResearch PersonnelCessation Of LifeGenesImmuneBioterrorism /Chemical Warfare
Grant awards (22)
Developing a Multiplex Assay to Detect Viral Pathogens Causing Hemorrhagic Fever$892,251
R56 · FY2010 · AI · contact PI
Innate Immunomodulating Genes of Smallpox Vaccines$342,172
U01 · FY2009 · AI · contact PI
Innate Immunomodulating Genes of Smallpox Vaccines$342,172
U01 · FY2008 · AI · contact PI
A SAFER AND MORE EFFICACIOUS SMALLPOX VACCINE$84,450
P51 · FY2008 · RR · contact PI
Innate Immunomodulating Genes of Smallpox Vaccines$348,529
U01 · FY2007 · AI · contact PI
A SAFER AND MORE EFFICACIOUS SMALLPOX VACCINE$57,422
P51 · FY2007 · RR · contact PI
Innate Immunomodulating Genes of Smallpox Vaccines$358,109
U01 · FY2006 · AI · contact PI
A SAFER AND MORE EFFICACIOUS SMALLPOX VACCINE$49,710
P51 · FY2006 · RR · contact PI
A Safer and More Efficacious Smallpox Vaccine$466,212
R01 · FY2005 · AI
Innate Immunomodulating Genes of Smallpox Vaccines$299,703
U01 · FY2005 · AI
A Safer and More Efficacious Smallpox Vaccine$609,811
R01 · FY2004 · AI
ENHANCED SAFETY &EFFICACY OF AIDS VACCINES BY IFN$209,543
P51 · FY2004 · RR
SAFER AND MORE EFFICACIOUS SMALLPOX VACCINES$75,511
P51 · FY2004 · RR
A Safer and More Efficacious Smallpox Vaccine$256,933
R01 · FY2003 · AI
Safer and More Efficacious Recombinant AIDS Vaccines$222,750
R21 · FY2003 · AI
ENHANCED SAFETY &EFFICACY OF AIDS VACCINES BY IFN$58,072
P51 · FY2003 · RR
INDUCTION OF MUCOSAL IMMUNITY WITH RECOMBINANT VACCINES$452,866
R01 · FY2002 · AI
Safer and More Efficacious Recombinant AIDS Vaccines$222,750
R21 · FY2002 · AI
ENHANCED SAFETY &EFFICACY OF AIDS VACCINES BY IFN ($0
P51 · FY2002 · RR
INDUCTION OF MUCOSAL IMMUNITY WITH RECOMBINANT VACCINES$445,776
R01 · FY2001 · AI
ENHANCED SAFETY &EFFICACY OF AIDS VACCINES BY IFN ($0
P51 · FY2001 · RR
INDUCTION OF MUCOSAL IMMUNITY WITH RECOMBINANT VACCINES$513,446
R01 · FY2000 · AI